Research Article

Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes

Figure 6

Tumor microenvironment analysis. (a, b) The difference of 22 kinds of immune cells between the high-expression group and the low-expression group according to the expression levels of TNFRSF14 and APOL2 was analyzed and shown by box plots. was marked as ; was marked as ; was marked as ; was marked as . (c, d) The correlation of the immunoproteasome of TNFRSF14 and risk score to survival status, TumorPurity, and inflammatory and immune responses. These responses were induced by immunoglobulin G (IgG), HCK, major histocompatibility complex class II (MHC-II), lymphocyte-specific kinase (LCK), major histocompatibility complex class I (MHC-I), activator of transcription 1 (STAT1), interferon, B7-CD28, and TNF.
(a)
(b)
(c)
(d)